Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Methods To evaluate the beneficial effects of GLP-1RAs on hepatic cholesterol metabolism, HepG2 cells were exposed to palmitic acid (PA) and subsequently treated with or without the GLP-1RAs, exendin-4 and liraglutide
Product Details : 10mL sterile vial Appearance: Red solution (due to B12 content) Storage: Refrigerate after opening Stability: Maintain sterile handling practices Important For research use only
Retatrutide Research Profile: Triple GIP/GLP-1/GCG Agonist Retatrutide a triple GIP/GLP-1/glucagon receptor agonist research profile and the documentation US laboratories expect
| | 5-Amino-1MQ Monotherapy | None | 50100mg daily | Daily oral or subcutaneous | NNMT inhibition preserves NAD+, activates AMPK and mitochondrial fat oxidation | 812 weeks | Promising preclinical data
US$ 22.81
US$ 20.94
US$ 20.75
US$ 23.15
US$ 22.05
US$ 20.60
